Department of Reproductive Medicine and IVF, Goztepe Medical Park Hospital, Istanbul, Turkey.
Department of Obstetrics and Gynecology, Nisantasi University and Private Medistate Hospital, Istanbul, Turkey.
An Bras Dermatol. 2021 Mar-Apr;96(2):171-175. doi: 10.1016/j.abd.2020.09.002. Epub 2021 Feb 2.
Pruritic urticarial papules and plaques of pregnancy development may have a strong relationship with hormone treatments during in vitro fertilization and hormonal changes during pregnancy.
The aim of this study was to evaluate and compare the frequency of papules and plaques of pregnancy and related factors in in vitro fertilization pregnancies and spontaneous pregnancies.
In this study, 517 in vitro fertilization pregnancies and 1253 spontaneous pregnancies were retrospectively reviewed for papules and plaques of pregnancy frequency. The diagnosis of papules and plaques of pregnancy was performed by referral to the dermatology department and according to the typical clinical manifestations of the disease.
The papules and plaques of pregnancy was more common in all in vitro fertilization pregnancies (including single pregnancies) than in spontaneous pregnancies. Age, Rh positivity, mother weight gain, onset of disease during gestation, duration of disease, birth weight and the frequency of male fetus were similar between the two groups (p>0.05). The rate of multiple pregnancies was higher in in vitro fertilization pregnancies with papules and plaques of pregnancy than in vitro fertilization pregnancies without papules and plaques of pregnancy (p<0.001). Duration of progesterone treatment was also significantly longer in in vitro fertilization pregnancies with papules and plaques of pregnancy compared to in vitro fertilization pregnancies without papules and plaques of pregnancy (p<0.001).
The limitations of the study were the retrospective and single-centered design.
The results of this study indicate that increased progesterone dosage or prolonged treatment may play a role in the pathogenesis papules and plaques of pregnancy.
妊娠瘙痒性荨麻疹性丘疹斑块的发生可能与体外受精过程中的激素治疗以及妊娠期间的激素变化有密切关系。
本研究旨在评估和比较体外受精妊娠和自然妊娠中妊娠瘙痒性荨麻疹性丘疹斑块的发生频率及其相关因素。
本研究回顾性分析了 517 例体外受精妊娠和 1253 例自然妊娠中妊娠瘙痒性荨麻疹性丘疹斑块的发生频率。通过皮肤科就诊和根据疾病的典型临床表现来诊断妊娠瘙痒性荨麻疹性丘疹斑块。
所有体外受精妊娠(包括单胎妊娠)中妊娠瘙痒性荨麻疹性丘疹斑块的发生率均高于自然妊娠。两组间年龄、Rh 阳性、母亲体重增加、发病孕期、疾病持续时间、出生体重和男胎比例相似(p>0.05)。有妊娠瘙痒性荨麻疹性丘疹斑块的体外受精妊娠中多胎妊娠的发生率高于无妊娠瘙痒性荨麻疹性丘疹斑块的体外受精妊娠(p<0.001)。有妊娠瘙痒性荨麻疹性丘疹斑块的体外受精妊娠中孕酮治疗持续时间也明显长于无妊娠瘙痒性荨麻疹性丘疹斑块的体外受精妊娠(p<0.001)。
本研究的局限性在于回顾性和单中心设计。
本研究结果表明,孕酮剂量增加或治疗时间延长可能在妊娠瘙痒性荨麻疹性丘疹斑块的发病机制中起作用。